PBSV — Pharma-Bio Serv Balance Sheet
0.000.00%
- $10.27m
- -$2.17m
- $9.51m
- 70
- 58
- 39
- 56
Annual balance sheet for Pharma-Bio Serv, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | C2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17.1 | 17.5 | 14.5 | 15 | 12.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11 | 4.61 | 4.98 | 3.94 | 2.51 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 28.6 | 22.8 | 19.9 | 19.4 | 15.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.06 | 0.745 | 0.576 | 0.389 | 0.368 |
Other Long Term Assets | |||||
Total Assets | 29.9 | 23.9 | 20.7 | 19.9 | 16.3 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.79 | 2.67 | 2.11 | 2.15 | 1.89 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.2 | 5.01 | 4.09 | 3.78 | 2.58 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 22.7 | 18.9 | 16.6 | 16.1 | 13.7 |
Total Liabilities & Shareholders' Equity | 29.9 | 23.9 | 20.7 | 19.9 | 16.3 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |